Multiorgan failure and macrophage activation syndrome in adult-onset Still´s disease

Czech version

Authors: J. Tomš ¹; T. Soukup ¹; J. Polák ²; P. Bradna ¹
Authors‘ workplace: 2. interní klinika, oddělení revmatologie, Lékařská fakulta UK a Fakultní nemocnice Hradec Králové ¹; Klinika anesteziologie, resuscitace a intenzivní medicíny, Lékařská fakulta UK a Fakultní nemocnice Hradec Králové ²
Published in: Čes. Revmatol., 20, 2012, No. 3, p. 133-137.
Category: Case Report

Overview

Macrophage activation syndrome (MAS) is a relatively rare and potentially life threatening complication of autoimmune systemic diseases, mainly systemic juvenile idiopathic arthritis. It is characterized by persistent fever, cytopenia, internal organ dysfunction and coagulopathy on the basis of activation and proliferation of T-lymphocytes and macrophages with uncontrolled cytokine release (so called „cytokine storm“). The authors present a case of 36-year-old woman with simultaneous manifestation of adult-onset Stillęs disease and MAS. Multiorgan failure required a complex intensive care, lasting several weeks. The combined immunosuppressive therapy led to the remission of both diseases.

Key words:
macrophage activation syndrome, adult-onset Stillęs disease, multiorgan failure

Sources

1. Still GF. On a form of chronic joint disease in children. Med Chir Trans 1897; 80: 47.

2. Bywaters EG. Stillęs disease in the adult. Ann Rheum Dis 1971; 30: 121.

3. Yamaguchi M, Ohta A, Tsunematsu T. Preliminary criteria for classification of adult Stillęs disease. J Rheumatol 1992; 19: 424-430.

4. Deane S, Selmi C, Teuber SS, Gershwin ME. Macrophage Activation Syndrome in Autoimmune Disease. Int Arch Allergy Immunol 2010; 153: 109-120.

5. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: A potentially fatal complication of rheumatic disorders. Arch Dis Child 2001; 85: 421-426.

6. Behrens EM, Beukelman T, Paessler M, Cron RQ. Ocult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007; 34: 1133-1138.

7. Parodi A, Davi S, Pringe AB, Pistorio A, Ruperto N, Magn-manzoni S, et al. Macrophage Activation syndrome in Juvenile Systemic Lupus Erythematosus. Arthritis Rheum 2009; 60(11): 3388-3399.

8. Athreya BH. Is macrophage activation syndrome a new entity? Clin Exp. Rheumatol 2002; 20: 121-123.

9. Ramanan AV, Schneider R. Macrophage activation syndrome – whatęs in a name? J Rheumatol 2003; 30: 2513-2516.

10. Ravelli A, Martini A. macrophage activation syndrome. In: Lehman TH, Cimaz R. Pediatric rheumatology. Amsterdam: Elservier, 2008, str. 55-63.

11. Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A. natural killer cell dysfunction in patients with systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003; 142: 292-296.

12. Ramanan AV, Schneider R. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol 2003; 30(2): 401-403.

13. Arlet JB, Le Thi Huong D, Marinho A, Amoura Z, Wechsler B, Papo T, Piette JC. Reactive hemophycocytic syndrome in adult-onset Stillęs disease: a report of six patients and a review of the literature. Ann Rheum Dis 2006; 65(12): 1596-1601.

14. Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG. Adult-onset Stillęs disease: clinical presantation in a large cohort of Italian patients. Clin Exp Rheumatol 2010; 28: 41-48.

15. Ravelli A, Magni-manzoni S, Pistorio A, Besana C, Foti T, Ruperto N et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005; 146: 598-604.

16. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cykclosporin A in th treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 1996; 129(5): 750.-754

17. Ravelli A, De benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis succaessfully treated with cyclosporine. J Pediatr 1996; 128: 275-278.

18. Cortis E, Insalaco A. Macrophage activation syndrome in juvenile idiopathic arthritis. Acta Paediatr Suppl 2006; 95: 38-41.

19. Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 2004; 124: 4-14.

20. Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, et al. Treatment of hemophagocytic lymphohistocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367-2373.

21. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002; 14(5): 548-552.

Labels

Dermatology & STDs Paediatric rheumatology Rheumatology

Treatment of osteoarthritis

Article was published in

Czech Rheumatology

2012 Issue 3